IntelGenx Appoints André Godin as President

Oral drug delivery company, IntelGenx, has appointed André Godin to the position of president in addition to his current position as the company’s chief financial officer. 
 
In his newly expanded role, Mr. Godin will have overall responsibility for day-to-day operations, financial reporting and budgeting, as well as managing the company's relationships and interactions with the investment community. He will continue to report to the company’s chief executive officer, Horst Zerbe.
 
"In the time that I have worked with André as a member of IntelGenx’s senior management team, he has earned both my deep personal admiration and great professional respect," said Dr. Zerbe. "André’s contributions to IntelGenx have already been immeasurable and he is exceptionally well qualified to take on this expanded role. I look forward to continue working with and support him as we build on IntelGenx’s success."
 
Mr. Godin most recently served as IntelGenx’s executive vice president and chief financial officer. Before joining IntelGenx in 2015, he was interim CEO and CFO of Neptune Technologies and Bioresources.

Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.